#United States #Children's Hospital #Aurora #Food Allergies #Sublingual Immunotherapy

New Treatment for Food Allergies at Children's Hospital Colorado

In a significant advancement in pediatric healthcare, Children's Hospital Colorado is excited to announce the launch of a Sublingual Immunotherapy Program at its Anschutz Medical Campus in Aurora. This innovative program aims to expand the treatment options available for children suffering from various food allergies. The program is specifically designed to support the safe and effective development of tolerance to up to ten common food allergens.

The therapy utilizes daily oral drops that are administered under the tongue. This method of immunotherapy allows children to gradually build their tolerance to allergens, which may include milk, egg, peanut, cashew, walnut, almond, hazelnut, and sesame, with the potential to add soy and wheat in the future. Designed for families seeking long-term solutions, the program starts with closely monitored treatments at the hospital followed by daily at-home therapy.

Program Overview

Children enrolled in the Sublingual Immunotherapy Program will undergo a structured treatment plan, which begins with four supervised visits to the Food Challenge and Research Unit at Children's Colorado. Here, they will receive precise and controlled doses of allergens aimed at stimulating their immune systems. Upon successful completion, families will take the therapy home as they continue to build immunity in a controlled manner.

According to the director of Food Immunotherapies, Dr. Allison Hicks, every child and family have unique needs when it comes to managing food allergies. This program not only aids in gradual tolerance but also enhances family peace of mind by reducing the risks associated with accidental exposure to allergens. Dr. Hicks emphasized the importance of adaptability in treatment routes, explaining that health care teams collaborate with families to find the most suitable path based on individual circumstances.

The initiative recognizes the varying response rates among age groups, noting that younger children generally respond more favorably to this type of treatment. Hence, the program is open to children of all ages, encouraging early intervention where possible.

Clinical Considerations

While sublingual immunotherapy presents an exciting new avenue for managing food allergies, it is essential to note that it has not received FDA approval for this specific application as of yet. Participants will be required to obtain prescriptions through the hospital's outpatient pharmacy to receive their treatment. The most commonly reported side effect is temporary itching in the mouth, a mild irritation that typically subsides. Although sublingual immunotherapy can significantly decrease the risks and severity of allergic reactions, it is not regarded as a cure and should not replace active allergy management practices.

About Children's Hospital Colorado

Children's Hospital Colorado is one of the nation's leading nonprofit pediatric healthcare institutions, dedicated to improving the health of children through comprehensive medical care, education, research, and advocacy. Established in 1908, the hospital is consistently recognized among the best children's hospitals by U.S. News & World Report. With an extensive range of specialized pediatric services throughout Colorado, the hospital remains at the forefront of pediatric care innovation and research.

Families interested in learning more about the Sublingual Immunotherapy Program or other treatments offered can visit Children's Hospital Colorado's website for more information and support.

This groundbreaking program represents a crucial step forward in addressing food allergies within the pediatric community, further establishing Children's Hospital Colorado as a leading force in innovative therapies and holistic child health management.